Marc Cobo
VP of Finance & ControllerMr. Marc Cobo is Vice President of Finance & Controller at TheRas, Inc. since May 2025. He had been Executive Vice President and Chief Accounting Officer at SFJ Pharmaceuticals, Inc. since March 2021 until 2024. He served as Senior Vice President, Finance and Chief Accounting Officer at Tricida, Inc. since June 29, 2020 until December 04, 2020. Mr. Cobo has solid experience in corporate accounting, including mergers and acquisitions, compliance, public offering and financial analysis activities. Mr. Cobo served as Vice President of Finance at Sangamo Therapeutics, Inc. ("Sangamo"), a biotechnology company, with responsibility for accounting, procurement, IT and facilities from January 2018 to May 2019 and held various roles of increasing responsibilities within Sangamo since March 2014 (serving as Controller from October 2015 to December 2017 and Assistant Controller from March 2014 to September 2015). Prior to joining Sangamo, Mr. Cobo was a Senior Manager, Accounting, at Responsys, Inc., a software company, from June 2012 until March 2014 when the company was acquired by Oracle Corporation ("Oracle"). Prior to that position, Mr. Cobo held various roles of increasing responsibilities at Oracle, in the mergers and acquisition, technical accounting and SEC reporting teams, from November 2006 to June 2012. He started his career in audit at Ernst and Young LLP from 2002 to 2006 in the firm's biotechnology and technology practices. Mr. Cobo holds a B.S. in accounting from Santa Clara University and is a licensed Certified Public Accountant.
Positions
- Company NameBridgeBio Oncology Therapeutics, Inc.Stock CodeBBOTPositionVP of Finance & ControllerColleagues
- NKNeil KumarExecutive Chairman
- FPFrank P. McCormickCo-Founder, Non-Executive Director & Chair of the Advisory Board
- YBYong BenChief Medical & Development Officer
- PJPedro J. BeltranChief Executive Officer and Director
- JBJacob B. BauerIndependent Chairman of the Board
- PPPraveen P. TipirneniIndependent Director
